Evidence map›Paper›PMID 39762574›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

The relationship between electric field strength induced by electroconvulsive therapy and cognitive and antidepressant outcomes.

Dore Loef, Miklos Argyelan, Henricus G Ruhé, Dominique S Scheepens, Robert A Schoevers, Indira Tendolkar, Eric van Exel, Jeroen A van Waarde, Guido A van Wingen, Joey P A J Verdijk and 3 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dore LoefDepartment of Psychiatry, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. d.loef@ggzingeest.nl.ORCID http://orcid.org/0000-0002-4443-0139
Miklos ArgyelanFeinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA.ORCID http://orcid.org/0000-0002-7254-1776
Henricus G RuhéDepartment of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
Dominique S ScheepensDepartment of Psychiatry, Amsterdam UMC, location Academic Medical Center, Amsterdam, The Netherlands.
Robert A SchoeversDepartment of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-0760-9866
Indira TendolkarDepartment of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-3171-3671
Eric van ExelDepartment of Psychiatry, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Jeroen A van WaardeDepartment of Psychiatry, Rijnstate Hospital, Arnhem, The Netherlands.ORCID http://orcid.org/0000-0001-6792-5727
Guido A van WingenAmsterdam Neuroscience, Mood, Anxiety, Psychosis, Sleep & Stress Program, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3076-5891
Joey P A J VerdijkDepartment of Psychiatry, Rijnstate Hospital, Arnhem, The Netherlands.
Esmée VerwijkDepartment of ECT, Parnassia Psychiatric Institute, The Hague, The Netherlands.
Annemiek DolsDepartment of Psychiatry, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Philip F P van EijndhovenDepartment of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

ZonMw (Netherlands Organisation for Health Research and Development) project number 60-63600-98-903
6 · The paper itself

Abstract

Electroconvulsive therapy (ECT) is an effective treatment for depression but is often associated with cognitive side effects. In patients, ECT-induced electric field (E-field) strength across brain regions varies significantly due to anatomical differences, which may explain individual differences in cognitive side effects. We examined the relationship between regional E-field strength and change in verbal fluency score (i.e., category fluency animals score from pre- to 1 week post-ECT; as key proxy of cognitive side effects) across different electrode placements in depressed patients. Secondary, we examined the relationship between regional E-field strength and depression outcome. Using T1 magnetic resonance imaging, we performed E-field modeling in a total of 109 patients. Linear mixed models were executed to analyze the relationship between E-field strength across all 118 brain regions and both cognitive and depression outcomes, while correcting for nuisance variables (e.g., age, total number of ECT sessions, and study cohort). We found that a higher E-field strength was significantly associated with a higher decline in verbal fluency (n = 71, false discovery rate [FDR] corrected p < 0.01) in several brain regions in the left hemisphere (e.g., temporal gyrus and operculum cortex). Moreover, numerous significant associations were found only in the 24 patients treated with right unilateral ECT. No significant relationships were found between regional E-field strength and depression outcome. In conclusion, significant associations between verbal fluency and E-field strength were found in areas crucial for linguistic processing and semantic memory. Our findings underscore the importance of considering individualized dosing strategies to optimize cognitive outcome in ECT, while maintaining its antidepressant efficacy.

Indexed as

BrainCognitionElectroconvulsive TherapyMajor Depressive DisorderAdultAgedAntidepressive AgentsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedTreatment OutcomeAntidepressive Agents

Identifiers

PMID39762574
PMCPMC12089365

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.